Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia

Natalie E Parks1, Robert A Vandorpe, Jeremy J Moeller

  • 1From the Division of Neurology, Department of Medicine (N.E.P.), and the Division of Neuroradiology, Department of Diagnostic Radiology (R.A.V.), Dalhousie University, Halifax, Nova Scotia, Canada; and the Department of Neurology (J.J.M.), Yale University, New Haven, CT.

Neurology
|November 13, 2013
PubMed

Insights

Aceruloplasminemia, a rare genetic disorder, caused progressive cognitive decline and iron accumulation in the brain and liver of a diabetic patient. This condition affects iron homeostasis, leading to severe neurological and hepatic iron overload.

Area of Science:

  • Neuroscience
  • Genetics
  • Metabolic Disorders

Background:

  • Aceruloplasminemia is a rare autosomal recessive disorder characterized by iron accumulation in the brain and other organs.
  • It results from mutations in the CP gene, leading to a deficiency in ceruloplasmin, a ferroxidase crucial for iron metabolism.
  • This deficiency disrupts iron homeostasis, causing neurodegeneration and systemic iron overload.

Observation:

  • A 55-year-old man with diabetes and alcohol abuse presented with diabetic ketoacidosis and progressive cognitive decline over five years.
  • Cerebral and hepatic iron accumulation was detected via MRI, alongside pigmentary retinopathy.
  • Laboratory tests revealed undetectable ceruloplasmin, low serum iron and copper, and elevated serum ferritin.

Findings:

  • The patient was diagnosed with aceruloplasminemia, confirmed by liver biopsy showing increased hepatocyte iron storage.
  • The clinical presentation was marked by severe neurological impairment and systemic iron overload.
  • Genetic analysis confirmed mutations in the CP gene, causative of aceruloplasminemia.

Implications:

  • This case highlights the importance of considering rare genetic disorders like aceruloplasminemia in patients with unexplained neurological decline and iron accumulation.
  • Early diagnosis and management of aceruloplasminemia are crucial to prevent severe neurological damage and systemic complications.
  • Further research into the pathogenesis and therapeutic strategies for aceruloplasminemia is warranted to improve patient outcomes.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42